Eyevensys is a privately owned company based in Paris. Eyevensys was founded in December 2008 on the basis of research work conducted through the INSERM lab UMRS872 directed by Professor Francine Behar-Cohen, then, Professor of medicine at Paris Descartes University, head of ophthalmology at Hotel Dieu and currently Chairman of the Hopital Jules Gonin of Lausanne, Switzerland. Eyevensys’ mission is to improve patient outcome through the development of innovative therapeutic solutions fulfilling critical unmet needs with current therapies in ophtalmology, with the aim to improve short and long term outcome, compliance and tolerability.
From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.